News
The company will use the investment to scale its platform and expand its proprietary database.
The tool embeds in the EHR and allows providers to write care workflows that deliver best practices and next steps.
The company will use the investment to expand its technology's current abilities, add capabilities to detect additional health conditions and drive global growth.
Earlier this year, the company received FDA clearance for its RPM system that collects data like skin temperature, auscultation and heart rate in the home.
Though funding has fallen this year, Dr. Sunny Kumar, partner at GSR Ventures, said there are still opportunities for startups that can prove their value.
It connects with over 40 brands of wireless medical devices and integrates with popular EMR platforms.
The startup has set up a subsidiary in New York using the proceeds from its first Series C round.
The HIPAA-compliant Skills capabilities were launched in 2019 to help patients connect with hospitals and health insurers using Alexa.
The collaboration will offer low-cost medications to employees and employers through a new platform dubbed EmsanaRx Plus.
Former CEO Elizabeth Holmes was sentenced to more than 11 years in prison last month.